Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
26
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
9
users have commented on this narrative
25
users have followed this narrative
11 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
CITIC Telecom International Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
55G Rollout And Digital Integration Will Drive Progress
Key Takeaways Expansion into 5.5G and international markets like Southeast Asia and Europe is set to drive revenue growth and diversification. Digital transformation initiatives, including AI and cloud integration, aim to boost operational efficiency and enhance margins.
View narrative
HK$3.10
FV
16.1% undervalued
intrinsic discount
4.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
Updated
narrative
Western Union
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Digital Transformation Will Expand Remittance Reach Amid Regulatory Uncertainty
Key Takeaways Expansion in digital services, AI integration, and new consumer offerings enhance cost efficiency, diversify revenue, and position the company for higher margins and long-term growth. Increased migration and urbanization drive resilient remittance demand, while early adoption of blockchain and stablecoin technologies offers new revenue and operational advantages.
View narrative
US$9.32
FV
6.8% undervalued
intrinsic discount
1.32%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
30
users have followed this narrative
3 days ago
author updated this narrative
Blade Air Mobility
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Critical Organ Transport And Joby Aviation Will Expand Healthcare Reach
Key Takeaways Demand growth in medical transport and healthcare trends provide strong foundations for sustained revenue and margin expansion. Strategic partnerships and digital platforms enable cost advantages, defensible recurring revenue, and long-term market leadership potential.
View narrative
US$5.83
FV
24.2% undervalued
intrinsic discount
7.27%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
9 days ago
author updated this narrative
Applied Industrial Technologies
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
US Manufacturing Trends And Automation Will Unlock New Value
Key Takeaways Strategic focus on automation, robotics, and digital platforms is expanding margins and reducing dependence on slower-growth distribution activities. Robust demand from infrastructure, manufacturing reshoring, and effective acquisitions is driving sustained revenue growth and long-term earnings potential.
View narrative
US$300.83
FV
11.2% undervalued
intrinsic discount
4.94%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
3 days ago
author updated this narrative
FibroGen
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Clinical Trials And Regulatory Advances Will Open US Markets
Key Takeaways Advancing precision oncology and rare disease treatments positions the company for future revenue growth and strong market opportunities in underserved populations. Liquidity improvements and strategic pipeline diversification reduce financial risk while enhancing long-term earnings stability and optionality.
View narrative
US$43.00
FV
74.0% undervalued
intrinsic discount
-3.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
9 days ago
author updated this narrative
Popular
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Digital Infrastructure And Puerto Rico Projects Will Improve Efficiency
Key Takeaways Investments in digital platforms and infrastructure modernization are set to improve operational efficiency, customer growth, and long-term revenue expansion. Strong regional presence and prudent risk management position Popular to benefit from rising loan demand, financial inclusion, and consistent earnings growth.
View narrative
US$135.38
FV
9.9% undervalued
intrinsic discount
10.36%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
3 days ago
author updated this narrative
Roivant Sciences
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Late-stage Trials For Brepocitinib And Batoclimab Will Unlock Potential, But Execution Risks Remain
Key Takeaways Successful clinical trials and strategic deals may improve revenue and net margins by focusing on high-value areas. Potential in-licensing and late-stage pipeline approvals could significantly enhance earnings and portfolio sales impact.
View narrative
US$17.00
FV
29.9% undervalued
intrinsic discount
148.75%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
25 days ago
author updated this narrative
Amalgamated Financial
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
ESG Banking And Digital Modernization Will Boost Future Value
Key Takeaways Focus on ESG-driven deposit growth, digital modernization, and expansion into high-growth markets is expected to enhance revenue stability and operational efficiency. Strategic relationship-building and scalable infrastructure investments support reliable balance sheet growth and position the company strongly amid industry consolidation.
View narrative
US$33.00
FV
9.0% undervalued
intrinsic discount
12.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Flowers Foods
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Low-Carb Trends And Retail Shifts Will Erode Margins
Key Takeaways Declining demand for traditional bread and growing consumer preference for fresh, minimally processed foods threatens Flowers Foods' core markets and long-term revenue growth. Increased price competition, retailer bargaining power, and compliance costs put downward pressure on profit margins and complicate efforts to transition to higher-margin products.
View narrative
US$16.29
FV
2.7% undervalued
intrinsic discount
1.37%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
Updated
narrative
Value any company in seconds
Popular companies